Sale disclosed
Masaru Matsuda
See Remarks
Common Stock
- Reported value
- $91.85K
- Reported price
- $25.0009 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Arcutis Biotherapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $456.21K by 2 insiders.
Showing the first 6 of 20 trades on this page.
See Remarks
Common Stock
Director
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
See Remarks
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
See Remarks
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| See Remarks | Common StockSale10b5-1 | 3,674$25.00 / share | $91.85K | Sep 16Filed Sep 18 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 822$6.52 / share | $5.36K | Sep 15Filed Sep 17 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 1,019$7.51 / share | $7.65K | Sep 15Filed Sep 17 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 2,255$8.63 / share | $19.46K | Sep 15Filed Sep 17 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 4,730$24.18 / share | $114.37K | Sep 15Filed Sep 17 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units822$6.52 exercise / conversion price | Not a separate purchase | Sep 15Filed Sep 17 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units1,019$7.51 exercise / conversion price | Not a separate purchase | Sep 15Filed Sep 17 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units2,255$8.63 exercise / conversion price | Not a separate purchase | Sep 15Filed Sep 17 · 2d later | SEC filing |
| See Remarks | Common StockSale10b5-1 | 9,989$25.03 / share | $249.99K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 11,148$7.51 / share | $83.72K | Aug 27Filed Aug 28 · 1d later | SEC filing |
| Director | Common StockSale | 11,148$25.03 / share | $279.03K | Aug 27Filed Aug 28 · 1d later | SEC filing |
| Director | Common StockOption exercise or conversion | 27,052$8.63 / share | $233.46K | Aug 27Filed Aug 28 · 1d later | SEC filing |
| Director | Common StockSale | 27,052$25.03 / share | $677.1K | Aug 27Filed Aug 28 · 1d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units11,148$7.51 exercise / conversion price | Not a separate purchase | Aug 27Filed Aug 28 · 1d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units27,052$8.63 exercise / conversion price | Not a separate purchase | Aug 27Filed Aug 28 · 1d later | SEC filing |
| Director | Common StockOption exercise or conversion | 1,072$7.51 / share | $8.05K | Aug 20Filed Aug 24 · 4d later | SEC filing |
| Director | Common StockSale | 1,072$26.04 / share | $27.91K | Aug 20Filed Aug 24 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units1,072$7.51 exercise / conversion price | Not a separate purchase | Aug 20Filed Aug 24 · 4d later | SEC filing |
| See Remarks | Common StockSale | 1,697$27.00 / share | $45.82K | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 822$6.52 / share | $5.36K | Aug 17Filed Aug 19 · 2d later | SEC filing |
Showing the latest 20 of 79 trades. Show all 79 trades
Arcutis Biotherapeutics, Inc. - Common stock (ARQT) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberArcutis Biotherapeutics, Inc. - Common stock (ARQT) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberArcutis Biotherapeutics, Inc. - Common stock (ARQT) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House member